BRNS - Barinthus Biotherapeutics Plc. - ADR
IEX Last Trade
1.315
0.035 2.662%
Share volume: 2,722
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.28
0.04
2.73%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-10 | 2023-03-24 | 2023-05-12 | 2023-08-10 | 2023-11-09 | 2024-03-20 | 2024-05-13 | |
| Total revenue | 17.063 M | 6.165 M | 6.457 M | 468.000 K | 334.000 K | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 17.063 M | 6.165 M | 6.457 M | 468.000 K | 334.000 K | 0.000 | 0.000 | 0.000 | |
| -63.87% | 4.74% | -92.75% | -28.63% | -100.00% | nan% | nan% | |||
| Operating expenses | 3.275 M | -1.388 M | 32.493 M | 21.952 M | 26.671 M | 16.105 M | 19.988 M | 17.119 M | |
| Selling general and admin | -6.445 M | -11.132 M | 20.308 M | 12.138 M | 13.128 M | 961.000 K | 13.615 M | 5.994 M | |
| Research and development | 9.720 M | 9.744 M | 12.185 M | 9.814 M | 13.543 M | 15.144 M | 6.373 M | 11.125 M | |
| Total expenses | 3.275 M | -1.388 M | 32.493 M | 21.952 M | 26.671 M | 16.105 M | 19.988 M | 17.119 M | |
| -142.38% | 2,440.99% | -32.44% | 21.50% | -39.62% | 24.11% | -14.35% | |||
| Operating income | 13.788 M | 7.553 M | -26.036 M | -21.484 M | -26.337 M | -16.105 M | -19.988 M | -17.119 M | |
| Ebit | 13.788 M | 7.553 M | -26.036 M | -21.484 M | -26.337 M | -16.105 M | -19.988 M | -16.914 M | |
| Pretax income | 14.774 M | 7.547 M | -23.182 M | -18.739 M | -24.960 M | -14.713 M | -18.110 M | -15.557 M | |
| -48.92% | -407.17% | -19.17% | 33.20% | -41.05% | 23.09% | -14.10% | |||
| Income tax | -915.000 K | -674.000 K | -2.019 M | -516.000 K | -1.136 M | -603.000 K | -820.000 K | -37.000 K | |
| Net income basic | 15.693 M | 8.242 M | -21.189 M | -18.180 M | -23.802 M | -14.072 M | -17.293 M | -15.489 M | |
| -47.48% | -357.09% | 14.20% | -30.92% | 40.88% | -22.89% | 10.43% | |||
| Net income | 15.693 M | 8.242 M | -21.189 M | -18.180 M | -23.802 M | -14.072 M | -17.293 M | -15.489 M | |
| -47.48% | -357.09% | 14.20% | -30.92% | 40.88% | -22.89% | 10.43% |